Recombinant Human GABRA1 Protein: Handling & Application Protocol

Recombinant Human GABRA1 Protein is a critical research tool for studying the alpha-1 subunit of the GABA type-A receptor, enabling mechanistic investigation of GABAergic inhibitory neurotransmission, receptor pharmacology, and related neurological disorders.

Product Name

Recombinant Human GABRA1 Protein

SKU

rp367822

Target Protein

GABRA1 (Gamma-Aminobutyric Acid Type A Receptor Subunit Alpha1)

Species Origin

Human

Recommended Storage

Store at -80 °C upon receipt; avoid repeated freeze-thaw cycles

Primary Research Applications

Receptor binding assays, ELISA, Western blot, functional inhibition studies

Background & Biological Significance

GABRA1 encodes the alpha-1 subunit of the gamma-aminobutyric acid type A (GABA-A) receptor, the principal mediator of fast inhibitory neurotransmission in the mammalian central nervous system. GABA-A receptors are pentameric ligand-gated chloride ion channels assembled from a diverse family of subunits (α1–6, β1–3, γ1–3, δ, ε, π, θ, ρ). The α1 subunit is the most abundantly expressed alpha isoform in the adult brain, playing a central role in sedation, anticonvulsant activity, and anterograde amnesia mediated by benzodiazepines.

Mutations in GABRA1 have been linked to several epilepsy syndromes, including childhood absence epilepsy and juvenile myoclonic epilepsy, making Recombinant Human GABRA1 Protein a valuable reagent for drug screening, mechanistic studies, and biomarker research in neurological disease.

Materials & Equipment Required

• Recombinant Human GABRA1 Protein (SKU: rp367822)
• Sterile, nuclease-free water or recommended reconstitution buffer (e.g., PBS, pH 7.4, containing 0.1% BSA as carrier protein)
• Microcentrifuge and low-protein-binding microcentrifuge tubes
• Ice bucket and dry ice for cold-chain handling
• Vortex mixer and brief benchtop centrifuge
• Protein quantification reagents (e.g., BCA or Bradford assay kit)
• SDS-PAGE and Western blot apparatus (for QC verification)
• Appropriate assay buffers matched to downstream application (binding assay buffer, ELISA coating buffer, etc.)

Note: Always use low-protein-binding plasticware to minimize surface adsorption losses, especially at sub-microgram working concentrations.

Step-by-Step Reconstitution & Storage Protocol

1. Thaw carefully: Remove the vial from -80 °C storage and allow it to thaw slowly on ice (approximately 10–15 minutes). Do not thaw at 37 °C to avoid protein denaturation.
2. Brief centrifugation: Spin the vial at 500–1000 × g for 30 seconds to collect any lyophilized material from the cap and walls.
3. Reconstitution: Add the recommended volume of sterile reconstitution buffer (consult the product datasheet for the specific buffer and volume; typically sterile PBS pH 7.4 with 0.1% BSA) gently along the vial wall. Do not pipette directly onto the lyophilized cake.
4. Gentle mixing: Allow the vial to stand for 5–10 minutes at room temperature, then gently swirl or pipette slowly to dissolve. Avoid vigorous vortexing, which can denature the protein.
5. Protein quantification: Measure the protein concentration using a BCA or Bradford assay and compare with the certificate of analysis (CoA) specification.
6. Aliquoting: Prepare single-use aliquots in low-protein-binding tubes to avoid repeated freeze-thaw cycles. Label aliquots with date and lot number.
7. Storage: Store working aliquots at -80 °C. For short-term use within 1 week, aliquots may be kept at 4 °C. Avoid more than two freeze-thaw cycles.

Critical: Adding a carrier protein (0.1–0.5% BSA or 5–10% glycerol) to the reconstitution buffer is strongly recommended to stabilize the protein and prevent adsorptive loss during storage and assay setup.

Application Guidelines & Working Concentrations

Recombinant Human GABRA1 Protein is suitable for multiple research applications. The following guidelines reflect general best practices; researchers should optimize conditions empirically for their specific experimental system:

• ELISA (coating antigen): Typical coating concentrations range from 0.5–4 µg/mL in carbonate-bicarbonate buffer (pH 9.6). Optimize by checkerboard titration with your detection antibody.
• Western Blot (positive control): Load 50–200 ng per lane under denaturing (SDS-PAGE) conditions. Expect a band at the predicted molecular weight; verify against the CoA.
• Receptor Binding / Functional Assays: Working concentrations vary widely by assay design. Perform a full concentration-response curve starting from 0.1 nM to 1 µM to establish EC50 or IC50 values relevant to your experimental question.
• Protein–Protein Interaction (pull-down, SPR): Use at concentrations recommended in the specific assay system; typically 1–10 µg/mL for immobilization on chip or bead surfaces.

Quality Control Check: Prior to use in critical experiments, confirm protein integrity by SDS-PAGE (reducing and non-reducing) and verify identity by Western blot using a validated anti-GABRA1 antibody.

Troubleshooting & Critical Precautions

Problem	Likely Cause	Recommended Action
Low or no signal in ELISA/WB	Protein denaturation due to improper thawing or excess freeze-thaw	Thaw on ice; use fresh single-use aliquots; verify protein integrity by SDS-PAGE
Unexpected molecular weight band	Glycosylation differences, protein aggregation, or degradation	Compare with CoA; run under both reducing and non-reducing conditions; check storage history
High background or non-specific binding	Insufficient blocking or carrier protein absent in dilution buffer	Optimize blocking (5% BSA or milk); add 0.1% BSA to all dilution steps
Protein precipitates after reconstitution	Reconstitution buffer incompatibility or concentration too high	Spin at 10,000 × g for 5 min; use supernatant; reduce reconstitution concentration
Irreproducible functional assay results	Lot-to-lot variation or suboptimal assay conditions	Always include internal positive control; document lot numbers; pre-warm buffers to assay temperature

Safety Note: Handle all recombinant proteins according to standard laboratory biosafety guidelines. Although Recombinant Human GABRA1 Protein is not classified as a biohazard, follow institutional biosafety protocols and refer to the Safety Data Sheet (SDS) supplied with the product.

Frequently asked questions

What is the recommended reconstitution buffer for Recombinant Human GABRA1 Protein?

The product datasheet (CoA) supplied with SKU rp367822 specifies the optimal reconstitution buffer and volume. In general, sterile PBS (pH 7.4) supplemented with 0.1% BSA as a carrier protein is widely used for recombinant receptor subunit proteins to maintain stability and minimize adsorptive loss. Always consult the lot-specific CoA for definitive instructions.

How many freeze-thaw cycles can Recombinant Human GABRA1 Protein tolerate?

To preserve protein integrity and biological activity, it is strongly recommended to limit freeze-thaw cycles to a maximum of two. Upon initial reconstitution, the protein should be aliquoted into single-use volumes in low-protein-binding tubes and stored at -80 °C. Each repeated freeze-thaw event risks protein denaturation, aggregation, and loss of functional activity.

Which assay applications is Recombinant Human GABRA1 Protein validated for?

Recombinant Human GABRA1 Protein (rp367822) is suitable for applications including ELISA (as a coating antigen or standard), Western blot (as a positive control), receptor-ligand binding assays, and protein-protein interaction studies. Researchers should verify suitability for their specific assay format and optimize working concentrations empirically, as performance may vary by experimental system.

How can I verify the quality and integrity of the protein before use?

Run the reconstituted protein on SDS-PAGE under both reducing and non-reducing conditions and stain with Coomassie or silver stain to check for the expected band at the predicted molecular weight and to detect aggregation or degradation. Additionally, confirm protein identity using Western blot with a validated anti-GABRA1 antibody, and compare measured protein concentration against the CoA specification using a BCA or Bradford assay.

Is Recombinant Human GABRA1 Protein suitable for in vivo animal studies?

Recombinant Human GABRA1 Protein (rp367822) is intended for in vitro research use only and is not approved for in vivo administration, diagnostic, or therapeutic use. Researchers planning in vivo studies should consult their institutional biosafety committee and refer to the product SDS for full safety information.

References

1. Olsen RW, Sieghart W. GABA A receptors: subtypes provide diversity of function and pharmacology. Neuropharmacology. 2009;56(1):141-148. doi:10.1016/j.neuropharm.2008.07.045
2. Macdonald RL, Kang JQ, Gallagher MJ. Mutations in GABAA receptor subunits associated with genetic epilepsies. J Physiol. 2010;588(Pt 11):1861-1869. doi:10.1113/jphysiol.2010.186999
3. Aladdin Scientific. Recombinant Human GABRA1 Protein Product Datasheet, SKU rp367822. Aladdin Scientific.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.